These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 37921068

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.
    Xu K, Zhan Y, Yuan Z, Qiu Y, Wang H, Fan G, Wang J, Li W, Cao Y, Shen X, Zhang J, Liang X, Yin P.
    Mol Ther; 2019 Oct 02; 27(10):1810-1824. PubMed ID: 31208913
    [Abstract] [Full Text] [Related]

  • 7. IFI6 Downregulation Reverses Oxaliplatin Resistance of Colorectal Cancer Cells by Activating the ROS-Induced p38MAPK Signaling Pathway.
    Huang C, Zhou T, Ma L, Zhao S.
    Biol Pharm Bull; 2023 Oct 02; 46(1):26-34. PubMed ID: 36596524
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.
    Xu K, Chen G, Qiu Y, Yuan Z, Li H, Yuan X, Sun J, Xu J, Liang X, Yin P.
    Oncotarget; 2017 Mar 28; 8(13):21719-21732. PubMed ID: 28423513
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S, Li W, Sun H, Wu B, Ji F, Sun T, Chang H, Shen P, Wang Y, Zhou D.
    BMC Cancer; 2015 Dec 16; 15():969. PubMed ID: 26674205
    [Abstract] [Full Text] [Related]

  • 13. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway.
    Sun C, Wang FJ, Zhang HG, Xu XZ, Jia RC, Yao L, Qiao PF.
    World J Gastroenterol; 2017 Mar 14; 23(10):1816-1827. PubMed ID: 28348487
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
    Tong D, Zou E, Bai L, Ma J, Guo N, Wang H, Jiang L.
    J BUON; 2020 Mar 14; 25(5):2205-2214. PubMed ID: 33277837
    [Abstract] [Full Text] [Related]

  • 16. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C, Wang M, Wang J, Wu D, Gao Y, Huang K, Yao X.
    Biochem Pharmacol; 2021 Jul 14; 189():114390. PubMed ID: 33359068
    [Abstract] [Full Text] [Related]

  • 17. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
    Hua Y, Zhu Y, Zhang J, Zhu Z, Ning Z, Chen H, Liu L, Chen Z, Meng Z.
    Cell Physiol Biochem; 2018 Jul 14; 51(5):2148-2159. PubMed ID: 30522111
    [Abstract] [Full Text] [Related]

  • 18. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
    Alzoubi S, Brody L, Rahman S, Mahul-Mellier AL, Mercado N, Ito K, El-Bahrawy M, Silver A, Boobis A, Bell JD, Hajji N.
    Oncotarget; 2016 Jul 12; 7(28):44505-44521. PubMed ID: 27283986
    [Abstract] [Full Text] [Related]

  • 19. Hyaluronic Acid-Zein Core-Shell Nanoparticles Improve the Anticancer Effect of Curcumin Alone or in Combination with Oxaliplatin against Colorectal Cancer via CD44-Mediated Cellular Uptake.
    Liu L, Yang S, Chen F, Cheng KW.
    Molecules; 2022 Feb 23; 27(5):. PubMed ID: 35268597
    [Abstract] [Full Text] [Related]

  • 20. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
    Liang H, Xu Y, Zhang Q, Yang Y, Mou Y, Gao Y, Chen R, Chen C, Dai P.
    Artif Cells Nanomed Biotechnol; 2019 Dec 23; 47(1):725-736. PubMed ID: 30861353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.